HK1067950A1 - Negatively charged amphiphilic block copolymer as drug carrier and complex thereof with positively charged drug - Google Patents

Negatively charged amphiphilic block copolymer as drug carrier and complex thereof with positively charged drug

Info

Publication number
HK1067950A1
HK1067950A1 HK04109869A HK04109869A HK1067950A1 HK 1067950 A1 HK1067950 A1 HK 1067950A1 HK 04109869 A HK04109869 A HK 04109869A HK 04109869 A HK04109869 A HK 04109869A HK 1067950 A1 HK1067950 A1 HK 1067950A1
Authority
HK
Hong Kong
Prior art keywords
drug
block copolymer
amphiphilic block
complex
positively charged
Prior art date
Application number
HK04109869A
Other languages
English (en)
Inventor
Min-Hyo Seo
Han-Uk Kong In-Ja Choi
Original Assignee
Samyang Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Samyang Corp filed Critical Samyang Corp
Publication of HK1067950A1 publication Critical patent/HK1067950A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G81/00—Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers
    • C08G81/02—Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers at least one of the polymers being obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/66—Polyesters containing oxygen in the form of ether groups
    • C08G63/664—Polyesters containing oxygen in the form of ether groups derived from hydroxy carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
    • A61K47/6907—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a microemulsion, nanoemulsion or micelle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
    • B82B1/00—Nanostructures formed by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Nanotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK04109869A 2001-06-25 2004-12-14 Negatively charged amphiphilic block copolymer as drug carrier and complex thereof with positively charged drug HK1067950A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020010036203A KR100566911B1 (ko) 2001-06-25 2001-06-25 약물 전달체용 음이온기-함유 양친성 블록 공중합체 및 그의 양이온성 약물과의 복합체
PCT/KR2002/001074 WO2003000778A1 (en) 2001-06-25 2002-06-05 Negatively charged amphiphilic block copolymer as drug carrier and complex thereof with positively charged drug

Publications (1)

Publication Number Publication Date
HK1067950A1 true HK1067950A1 (en) 2005-04-22

Family

ID=36792807

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04109869A HK1067950A1 (en) 2001-06-25 2004-12-14 Negatively charged amphiphilic block copolymer as drug carrier and complex thereof with positively charged drug

Country Status (17)

Country Link
US (1) US6890560B2 (es)
EP (1) EP1399501B1 (es)
JP (1) JP4154328B2 (es)
KR (1) KR100566911B1 (es)
CN (1) CN1226332C (es)
AT (1) ATE337357T1 (es)
AU (1) AU2002303027C1 (es)
BR (1) BRPI0210335B8 (es)
CA (1) CA2449244C (es)
DE (1) DE60214173T2 (es)
ES (1) ES2269694T3 (es)
HK (1) HK1067950A1 (es)
IL (2) IL159166A0 (es)
MX (1) MXPA03011619A (es)
NZ (1) NZ530176A (es)
WO (1) WO2003000778A1 (es)
ZA (1) ZA200309357B (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003523544A (ja) * 2000-02-17 2003-08-05 レックスマーク・インターナショナル・インコーポレーテツド 導電性駆動ハブを備えたトナーカートリッジ
US7763663B2 (en) * 2001-12-19 2010-07-27 University Of Massachusetts Polysaccharide-containing block copolymer particles and uses thereof
US7311901B2 (en) 2003-10-10 2007-12-25 Samyang Corporation Amphiphilic block copolymer and polymeric composition comprising the same for drug delivery
CA2541445A1 (en) * 2003-10-31 2005-05-12 Teva Pharmaceutical Industries Ltd. Nanoparticles for drug delivery
ATE522548T1 (de) 2003-11-13 2011-09-15 Hanmi Holdings Co Ltd Verfahren zur massenproduktion der konstanten region von immunglobulin
US7179867B2 (en) * 2003-11-26 2007-02-20 Industrial Technology Research Institute Thermosensitive biodegradable copolymer
WO2005108471A1 (en) * 2004-05-05 2005-11-17 Firmenich Sa Biodegradable grafted copolymers
TW200700168A (en) * 2005-03-08 2007-01-01 Akrion Inc Method and system for processing substrates with sonic energy that reduces or eliminates damage to semiconductor devices
KR100773470B1 (ko) * 2005-04-25 2007-11-05 김태균 층간 소음 방지를 위한 방음판 구조
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
CN101400717B (zh) 2006-03-09 2011-08-31 科洛普拉斯特公司 具有用于软组织再生的改进生物相容性的可降解亲水嵌段共聚物
CN107080703A (zh) 2006-12-01 2017-08-22 安特里奥公司 肽纳米粒子和其用途
AU2007329579A1 (en) 2006-12-01 2008-06-12 Anterios, Inc. Amphiphilic entity nanoparticles
KR100918524B1 (ko) * 2007-02-14 2009-09-21 성균관대학교산학협력단 온도 및 피에치 민감성 블록공중합체 고분자 하이드로겔을이용한 주사가능한 약물전달체 및 약물전달방법
EP2162117B1 (en) 2007-05-31 2018-02-21 Anterios, Inc. Nucleic acid nanoparticles and uses therefor
WO2009078756A1 (en) * 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance
WO2009078755A1 (en) * 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance
JP5755563B2 (ja) * 2008-05-13 2015-07-29 ユニヴァーシティ オブ ワシントン ミセル集合体
US8652506B2 (en) * 2008-06-05 2014-02-18 Boston Scientific Scimed, Inc. Bio-degradable block co-polymers for controlled release
CN105147608B (zh) * 2008-06-26 2019-12-10 安特里奥公司 真皮递送
EP2416763A4 (en) * 2009-04-06 2015-05-06 Mayo Foundation METHODS AND SUBSTANCES FOR DELIVERING MOLECULES
KR101220162B1 (ko) * 2009-07-02 2013-01-14 한양대학교 산학협력단 아르기닌―기제 양친성 펩티드 마이셀
KR101249389B1 (ko) * 2010-10-28 2013-04-03 재단법인대구경북과학기술원 자극반응성 수화젤
KR101685646B1 (ko) * 2010-12-29 2016-12-13 한화케미칼 주식회사 홍합 접착단백질 모방을 통한 나노입자를 수계 매질에 분산시키는 생체적합성 분산 안정화제
KR101230598B1 (ko) 2011-02-28 2013-02-15 부산대학교 산학협력단 페하 응답성을 가지는 히스트딘이 공유결합된 덱스트란과 메톡시폴리에틸렌글리콜 블록공중합체
CA3160394C (en) 2013-07-30 2023-11-07 Genevant Sciences Gmbh Block copolymers and their conjugates or complexes with oligonucleotides
CA2923160A1 (en) 2013-09-09 2015-03-12 Canimguide Therapeutics Ab Immune system modulators
WO2016144650A1 (en) 2015-03-06 2016-09-15 Canimguide Therapeutics Ab Immune system modulators and compositions
CN105362251B (zh) * 2015-12-14 2019-02-26 四川大学 DOTAP-mPEG-PLA纳米粒及其纳米粒溶液、载药复合物和制备方法和应用
JP2019535829A (ja) 2016-11-21 2019-12-12 エイリオン セラピューティクス， インコーポレイテッド 大型薬剤の経皮送達
EP3562510A4 (en) 2016-12-30 2021-01-06 Genevant Sciences GmbH BRANCHED PEG MOLECULES AND ASSOCIATED COMPOSITIONS AND PROCEDURES
US11590080B2 (en) 2017-12-18 2023-02-28 C.R. Bard, Inc. Drug-loaded biodegradable microbead compositions including drug-containing vesicular agents
CN112004528B (zh) * 2017-12-18 2023-01-03 巴德股份有限公司 载药微珠组合物、栓塞组合物和相关方法
CN110742903B (zh) * 2019-11-22 2021-06-01 兰州大学 含铑(ⅰ)的聚合物胶束、其制备方法与应用
EP4380546A1 (en) 2021-08-05 2024-06-12 MedinCell S.A. Pharmaceutical composition
US20230126744A1 (en) * 2021-10-25 2023-04-27 The Secant Group, Llc. Polymeric delivery systems

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3677019D1 (de) 1986-11-21 1991-02-21 Agfa Gevaert Nv Oberflaechenaktives polymer.
US5035972A (en) 1989-10-31 1991-07-30 E. I. Du Pont De Nemours And Company AB diblock copolymers as charge directors for negative electrostatic liquid developer
CA2029631A1 (en) * 1989-11-22 1991-05-23 Kathleen A. Hughes Graft polymers as biodegradable detergent additives
NL9100218A (nl) * 1991-02-07 1992-09-01 Philips Nv Encodeer/decodeer-schakeling, alsmede digitaal video-systeem voorzien van de schakeling.
US5567410A (en) * 1994-06-24 1996-10-22 The General Hospital Corporation Composotions and methods for radiographic imaging
US5783178A (en) 1994-11-18 1998-07-21 Supratek Pharma. Inc. Polymer linked biological agents
JP2690276B2 (ja) 1995-01-10 1997-12-10 科学技術振興事業団 静電結合型高分子ミセル薬物担体とその薬剤
US5569448A (en) 1995-01-24 1996-10-29 Nano Systems L.L.C. Sulfated nonionic block copolymer surfactants as stabilizer coatings for nanoparticle compositions
JPH11510837A (ja) 1995-07-28 1999-09-21 フォーカル，インコーポレイテッド 薬物送達のための制御された放出薬剤および組織処置薬剤としての使用のためのマルチブロック生分解性ヒドロゲル
SI9620107A (sl) 1995-08-10 1998-10-31 Kazunori Kataoka Blok polimer, ki ima funkcionalne skupine na obeh svojih koncih
KR0180334B1 (ko) * 1995-09-21 1999-03-20 김윤 블럭 공중합체 미셀을 이용한 약물전달체 및 이에 약물을 봉입하는 방법
US6491903B1 (en) * 1996-06-27 2002-12-10 Washington University Particles comprising amphiphilic copolymers
EP1005324B1 (en) * 1997-06-13 2005-03-30 University Of Nebraska Board Of Regents Compositions for delivery of biological agents and methods for the preparation thereof
US6117949A (en) * 1998-10-01 2000-09-12 Macromed, Inc. Biodegradable low molecular weight triblock poly (lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
US6004573A (en) * 1997-10-03 1999-12-21 Macromed, Inc. Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
US6201072B1 (en) * 1997-10-03 2001-03-13 Macromed, Inc. Biodegradable low molecular weight triblock poly(lactide-co- glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
CN1281355A (zh) * 1997-12-12 2001-01-24 三阳株式会社 用于基因递送的生物可降解性混合聚合胶束
US6267987B1 (en) * 1997-12-12 2001-07-31 Samyang Corporation Positively charged poly[alpha-(omega-aminoalkyl) glycolic acid] for the delivery of a bioactive agent via tissue and cellular uptake
US5939453A (en) 1998-06-04 1999-08-17 Advanced Polymer Systems, Inc. PEG-POE, PEG-POE-PEG, and POE-PEG-POE block copolymers
US6715874B1 (en) * 1999-02-08 2004-04-06 Novartis Ag Organic polymers

Also Published As

Publication number Publication date
ATE337357T1 (de) 2006-09-15
EP1399501B1 (en) 2006-08-23
KR100566911B1 (ko) 2006-04-03
DE60214173D1 (de) 2006-10-05
BR0210335B1 (pt) 2014-06-24
MXPA03011619A (es) 2004-04-05
JP4154328B2 (ja) 2008-09-24
EP1399501A1 (en) 2004-03-24
AU2002303027B2 (en) 2005-06-09
AU2002303027C1 (en) 2006-06-01
ES2269694T3 (es) 2007-04-01
BR0210335A (pt) 2004-07-20
US20030017206A1 (en) 2003-01-23
WO2003000778A1 (en) 2003-01-03
CN1226332C (zh) 2005-11-09
CA2449244C (en) 2007-10-02
DE60214173T2 (de) 2007-08-23
IL159166A0 (en) 2004-06-01
CA2449244A1 (en) 2003-01-03
CN1520437A (zh) 2004-08-11
NZ530176A (en) 2005-06-24
ZA200309357B (en) 2005-05-25
US6890560B2 (en) 2005-05-10
IL159166A (en) 2007-12-03
KR20030000433A (ko) 2003-01-06
BRPI0210335B8 (pt) 2021-05-25
EP1399501A4 (en) 2005-02-16
JP2004530768A (ja) 2004-10-07

Similar Documents

Publication Publication Date Title
HK1067950A1 (en) Negatively charged amphiphilic block copolymer as drug carrier and complex thereof with positively charged drug
MXPA04000317A (es) Un copolimero de bloque amfifilico cargado positivamente como un vehiculo de medicamento y complejo del mismo con un medicamento cargado negativamente.
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
MY136095A (en) Use of human anti-ctla-4 antibodies for treatment of cancer
MXPA03010103A (es) Peptidos y composiciones anti-microbianos.
TW200727912A (en) Amphiphilic block copolymers and nano particles comprising the same
HK1048831A1 (en) Human ctla-4 antibodies and their uses
MXPA04001524A (es) 29-enoles de rapamicina.
WO2004069156A3 (en) Inactivated probiotic bacteria and methods of use thereof
AU8701501A (en) Elastomeric functional biodegradable copolyester amides and copolyester urethanes
AU2001235006A1 (en) Prophylactic and therapeutic monoclonal antibodies
AU2001247968A1 (en) Use of asiatic acid or asiaticoside for treatment of cancer
AU2003279567A1 (en) Sterilizing polymers and preparation and use thereof
YU68702A (sh) Novi lhrh-antagonisti, njihova proizvodnja i upotreba kao leka
AR034493A1 (es) Combinacion de principios activos para el tratamiento medico de toxicomanias.
AU7918500A (en) Substituted diazepanes
MY134019A (en) Aryl oxime-piperazines useful as ccr5 antagonists
PL357999A1 (en) Lhrh-antagonists, production and use thereof as medicament
WO2003017817A3 (en) Diagnosis, prevention and treatment of cancer
MY138219A (en) Biologically active peptides
WO2004019965A3 (en) Thymus-based tolerogenic approaches for type i diabetes.
ES2190581T3 (es) 2-aminotetralina opticamente activa, procedimiento para su preparacion y composiciones farmaceuticas que la contienen, activa en la prevencion y tratamiento de shock septico.
BR0008791A (pt) Derivados anticonvulsivos, úteis no tratamento de tremor essencial
EP1370697A4 (en) PEROXYREDOXIN-BASED MEDICINAL PRODUCTS FOR THE TREATMENT OF HIV-1 INFECTIONS AND METHODS OF USE
FR2869909B1 (fr) Peptide capable d'inhiber la polymerisation de la tubuline et son utilisation pour inhiber la proliferation cellulaire

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20220604